New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck.
Gommermann, N., Buehlmayer, P., von Matt, A., Breitenstein, W., Masuya, K., Pirard, B., Furet, P., Cowan-Jacob, S.W., Weckbecker, G.(2010) Bioorg Med Chem Lett 20: 3628-3631
- PubMed: 20483608 
- DOI: https://doi.org/10.1016/j.bmcl.2010.04.112
- Primary Citation of Related Structures:  
3MPM - PubMed Abstract: 
A novel series of pyrazolo[1,5a]pyrimidines was optimized to target lymphocyte-specific kinase (Lck). An efficient synthetic route was developed and SAR studies toward activity and selectivity are described, leading to Lck inhibitors with enzymatic, cellular and in vivo potency ...